Total Funding
66
66
Total FundingSeries A raised
Growth Score
-28 pts
Heat Score
-18 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
46164
Xenocor offers a suite of leading edge, fog-free, single-use endoscopes for minimally invasive surgical procedures.
- David McNally: Chief Executive OfficerPast Role: Conavi Medical (formerly Titan Medical), President and CEO
David Van Ness: Chief Technology OfficerPast Role: Xenocor, Vice President of Engineering
About the Company
Xenocor offers a suite of leading edge, fog-free, single-use endoscopes for minimally invasive surgical procedures. This technology emerged from the Center for Medical Innovation at the University of Utah. The current product offerings are FDA cleared, CE Marked and patent protected.
